Sparassis crispa suppresses mast cell-mediated allergic inflammation: Role of calcium, mitogen-activated protein kinase and nuclear factor-κB

International Journal of Molecular Medicine

Volumn 30, Issue 2, 2012, Pages 344-350

  Kim, Hui Hun ^a   Lee, Soyoung ^a   Singh, Thoudam S K ^a   Choi, Jin Kyeong ^a   Shin, Tae Yong ^b   Kim, Sang Hyun ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Woosuk University   (South Korea)

Author keywords

Allergic inflammation; Calcium; Histamine; Mast cells; Nuclear factor B; Sparassis crispa

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA GLUCAN; CALCIMYCIN; CALCIUM; HISTAMINE; HISTAMINE RELEASE INHIBITOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL MYRISTATE; PLANT EXTRACT; SPARASSIS CRISPA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL ACTIVATION; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOKINE RESPONSE; DOSE RESPONSE; DRUG DETERMINATION; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MALE; MAST CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; SKIN ANAPHYLAXIS; SPARASSIS CRISPA; SYSTEMIC ANAPHYLAXIS; SYSTEMIC DISEASE; TRANSCRIPTION INITIATION;

ANAPHYLAXIS; ANIMALS; CALCIUM; COMPLEX MIXTURES; CYTOKINES; ENZYME ACTIVATION; HISTAMINE RELEASE; HYPERSENSITIVITY; INFLAMMATION MEDIATORS; MALE; MAST CELLS; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P-METHOXY-N-METHYLPHENETHYLAMINE; POLYPORALES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84863547483     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1000     Document Type: Article

References (33)

1. Yoshikawa K, Kokudo N, Hashimoto T, Yamamoto K, Inose T and Kimura T: Novel phthalide compounds from Sparassis crispa (Hanabiratake), Hanabiratakelide A-C, exhibiting anticancer related activity. Biol Pharm Bull 33: 1355-1359, 2010.
2. Kwon AH, Qiu Z, Hashimoto M, Yamamoto K and Kimura T: Effects of medicinal mushroom (Sparassis crispa) on wound healing in streptozotocin-induced diabetic rats. Am J Surg 197: 503-509, 2009.
3. Yamamoto K, Kimura T, Sugitachi A and Matsuura N: Anti-angiogenic and anti-metastatic effects of beta-1,3-D-glucan purified from Hanabiratake, Sparassis crispa. Biol Pharm Bull 32: 259-263, 2009.
4. Tada R, Harada T, Nagi-Miura N, et al: NMR characterization of the structure of a beta-(1→3)-D-glucan isolate from cultured fruit bodies of Sparassis crispa. Carbohydr Res 342: 2611-2618, 2007.
5. Caughey GH: Mast cell proteases as protective and inflammatory mediators. Adv Exp Med Biol 716: 212-234, 2011.
6. Galli SJ, Tsai M and Piliponsky AM: The development of allergic inflammation. Nature 454: 445-454, 2008.
7. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM and Tsai M: Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23: 749-786, 2005.
8. Kim SH, Jun CD, Suk K, et al: Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci 91: 123-131, 2006.
9. Amin K: The role of mast cells in allergic inflammation. Respir Med 106: 9-14, 2012.
10. Lee DH, Kim SH, Eun JS and Shin TY: Mosla dianthera inhibits mast cell-mediated allergic reactions through the inhibition of histamine release and inflammatory cytokine production. Toxicol Appl Pharmacol 216: 479-484, 2006.
11. Tagen M, Elorza A, Kempuraj D, et al: Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content. J Immunol 183: 6313-6319, 2009.
12. 2+ entry and NFAT activation in lymphocytes. Cell Calcium 42: 145-156, 2007.
13. Bae Y, Lee S and Kim SH: Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-kappaB. Toxicol Appl Pharmacol 254: 56-64, 2011.
14. Kim SH, Lee S, Kim IK, et al: Suppression of mast cell-mediated allergic reaction by Amomum xanthiodes. Food Chem Toxicol 45: 2138-2144, 2007.
15. Lee S, Yun HS and Kim SH: The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 32: 9434-9443, 2011.
16. Lee S, Suk K, Kim IK, et al: Signaling pathways of bisphenol A-induced apoptosis in hippocampal neuronal cells: role of calcium-induced reactive oxygen species, mitogen-activated protein kinases, and nuclear factor-kappaB. J Neurosci Res 86: 2932-2942, 2008.
17. Eisenhut M and Wallace H: Ion channels in inflammation. Pflugers Arch 461: 401-421, 2011.
18. Shin TY, Kim SH, Suk K, et al: Anti-allergic effects of Lycopus lucidus on mast cell-mediated allergy model. Toxicol Appl Pharmacol 209: 255-262, 2005.
19. Kim GY, Lee JW, Ryu HC, Wei JD, Seong CM and Kim JH: Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis. J Immunol 184: 3946-3954, 2010.
20. Park HH, Lee S, Oh JM, et al: Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacol Res 55: 31-37, 2007.
21. Arbabi S and Maier RV: Mitogen-activated protein kinases. Crit Care Med 30 (Suppl 1): S74-S79, 2002.
22. Kim SH, Choi CH, Kim SY, Eun JS and Shin TY: Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp Biol Med (Maywood) 230: 82-88, 2005.
23. Boden SR and Wesley Burks A: Anaphylaxis: a history with emphasis on food allergy. Immunol Rev 242: 247-257, 2011.
24. Jutel M, Blaser K and Akdis CA: Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol 137: 82-92, 2005.
25. Palomaki VA and Laitinen JT: The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sections. Br J Pharmacol 147: 596-606, 2006.
26. Kim SY, Kim SH, Shin HY, et al: Effects of Prunella vulgaris on mast cell-mediated allergic reaction and inflammatory cytokine production. Exp Biol Med (Maywood) 232: 921-926, 2007.
27. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D and Murphy GF: Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88: 4220-4224, 1991.
28. Stone KD, Prussin C and Metcalfe DD: IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125 (Suppl 2): S73-S80, 2010.
29. Galli SJ, Gordon JR and Wershil BK: Cytokine production by mast cells and basophils. Curr Opin Immunol 3: 865-872, 1991.
30. Thomas PS: Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol 79: 132-140, 2001.
31. Mican JA, Arora N, Burd PR and Metcalfe DD: Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J Allergy Clin Immunol 90: 815-824, 1992.
32. Karin M: NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1: a000141, 2009.
33. Dong C, Davis RJ and Flavell RA: MAP kinases in the immune response. Annu Rev Immunol 20: 55-72, 2002.